Patent ID: 9744149
Date: 2017-08-29
CPC Classifications: A61K

Claim:
1. A method of treating, inhibiting, or reducing the severity of ER-(+) AR-(+) metastatic breast cancer in a subject suffering from ER-(+) AR-(+) metastatic breast cancer, wherein said breast cancer has been previously treated with at least one prior hormone therapy, the method comprising administering to said subject a selective androgen receptor modulator (SARM) compound represented by a structure of Formula I: X is O; G is O; T is OH, OR, —NHCOCH R is alkyl, dihaloalkyl, trihaloalkyl, CH R R R Z is NO Y is CF Q is CN, alkyl, halogen, N(R) n is an integer of 1-4; and m is an integer of 1-3; and wherein said treating does not include preventing.